We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Simple Blood Tests Improve Hypertension Treatment

By LabMedica International staff writers
Posted on 17 May 2017
Print article
African and African American hypertensives tend to retain salt and water, with lower levels of plasma renin and more resistant hypertension. Two simple blood tests were able to drastically improve treatment for resistant hypertension across three sites in Nigeria, Kenya and South Africa.

By testing patients' levels of plasma renin, a protein secreted by the kidneys, in combination with levels of aldosterone, a hormone that causes salt and water retention, physicians were able to identify the physiological changes causing the hypertension. This led to personalized and more accurate therapy.

An international team of scientists under the auspices of Western University enrolled patients at hypertension clinics in Nigeria, Kenya, and South Africa with a systolic blood pressure greater than140 mm Hg or diastolic pressure greater than 90 mm Hg despite treatment were allocated to usual care (UC) versus physiologically individualized care (PhysRx). Plasma renin activity and aldosterone were measured using enzyme-linked immunosorbent assay (ELISA) kits. Patients were followed for one year; the primary outcome was the percentage of patients achieving blood pressure less than140 mm Hg and diastolic less than 90 mm Hg.

Of the 94 patients who completed the study, 42 were treated with the usual course of treatment, 52 were given the blood tests, and treatment was decided based on the results. In the group who were given usual treatment, 11.1% had controlled blood pressure after one year, versus 50% in the group that received the blood test. Systolic control was achieved in 13.9% of UC versus 60.3% of PhysRx; diastolic control in 36.1% of UC versus 67.2% of PhysRx.

The authors concluded that physiologically individualized therapy based on renin/aldosterone phenotyping significantly improved blood pressure control in a sample of African patients with uncontrolled hypertension. This approach should be tested in African American and other patients with resistant hypertension. J. David Spence, MBA, MD, FRCPC, a professor and lead investigator of the study said, “"If a patient has salt and water retention, it causes high blood pressure and also feeds back and shuts down both renin and aldosterone.” The study was published on May 2, 2017, in the American Journal of Hypertension.

Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Urine Drug Test
Instant-view Ecstasy (MDMA)
New
Uric Acid and Blood Glucose Meter
URIT-10

Print article

Channels

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The ready-to-use DUB enzyme assay kits accelerate routine DUB activity assays without compromising data quality (Photo courtesy of Adobe Stock)

Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation

Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.